image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 2.575
-0.791 %
$ 291 M
Market Cap
-0.71
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one DH stock under the worst case scenario is HIDDEN Compared to the current market price of 2.58 USD, Definitive Healthcare Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one DH stock under the base case scenario is HIDDEN Compared to the current market price of 2.58 USD, Definitive Healthcare Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one DH stock under the best case scenario is HIDDEN Compared to the current market price of 2.58 USD, Definitive Healthcare Corp. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DH

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
252 M REVENUE
0.31%
-711 M OPERATING INCOME
-115.53%
-591 M NET INCOME
-192.23%
58.2 M OPERATING CASH FLOW
41.29%
-26.4 M INVESTING CASH FLOW
16.91%
-56.7 M FINANCING CASH FLOW
-121.81%
62.3 M REVENUE
-0.65%
-99.6 M OPERATING INCOME
55.82%
-84.7 M NET INCOME
70.13%
8.14 M OPERATING CASH FLOW
-58.14%
-26.3 M INVESTING CASH FLOW
-293.16%
-13.4 M FINANCING CASH FLOW
-10.80%
Balance Sheet Definitive Healthcare Corp.
image
Current Assets 370 M
Cash & Short-Term Investments 290 M
Receivables 53.2 M
Other Current Assets 26.8 M
Non-Current Assets 719 M
Long-Term Investments 0
PP&E 11.3 M
Other Non-Current Assets 708 M
26.64 %4.89 %64.98 %Total Assets$1.1b
Current Liabilities 161 M
Accounts Payable 10.8 M
Short-Term Debt 2.41 M
Other Current Liabilities 148 M
Non-Current Liabilities 321 M
Long-Term Debt 15.2 M
Other Non-Current Liabilities 306 M
30.69 %3.15 %63.43 %Total Liabilities$482.2m
EFFICIENCY
Earnings Waterfall Definitive Healthcare Corp.
image
Revenue 252 M
Cost Of Revenue 54.7 M
Gross Profit 197 M
Operating Expenses 908 M
Operating Income -711 M
Other Expenses -119 M
Net Income -591 M
300m300m200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)(400m)(400m)(500m)(500m)(600m)(600m)(700m)(700m)(800m)(800m)252m(55m)197m(908m)(711m)119m(591m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
78.30% GROSS MARGIN
78.30%
-281.85% OPERATING MARGIN
-281.85%
-163.81% NET MARGIN
-163.81%
-68.04% ROE
-68.04%
-37.92% ROA
-37.92%
-71.28% ROIC
-71.28%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Definitive Healthcare Corp.
image
60m60m50m50m40m40m30m30m20m20m10m10m00202020202021202120222022202320232024202420252025
Net Income -591 M
Depreciation & Amortization 51.7 M
Capital Expenditures 0
Stock-Based Compensation 38.1 M
Change in Working Capital -25.9 M
Others 674 M
Free Cash Flow 58.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Definitive Healthcare Corp.
image
Wall Street analysts predict an average 1-year price target for DH of $6.31 , with forecasts ranging from a low of $4 to a high of $8 .
DH Lowest Price Target Wall Street Target
4 USD 55.34%
DH Average Price Target Wall Street Target
6.31 USD 145.15%
DH Highest Price Target Wall Street Target
8 USD 210.68%
Price
Max Price Target
Min Price Target
Average Price Target
88776655443322Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Definitive Healthcare Corp.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
212 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). globenewswire.com - 4 weeks ago
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare's new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare's new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings' and Mr. Graboske's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). globenewswire.com - 1 month ago
New Strong Sell Stocks for March 4th Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025. zacks.com - 1 month ago
Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host. seekingalpha.com - 2 months ago
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago. zacks.com - 2 months ago
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024. globenewswire.com - 2 months ago
Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the Raymond James 2025 Institutional Investors Conference. globenewswire.com - 2 months ago
DH or FFIV: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2 months ago
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. globenewswire.com - 2 months ago
A Dive Into Definitive Healthcare Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below. seekingalpha.com - 2 months ago
DH vs. FFIV: Which Stock Is the Better Value Option? Investors looking for stocks in the Internet - Software sector might want to consider either Definitive Healthcare Corp. (DH) or F5 Networks (FFIV). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 2 months ago
Definitive Healthcare (DH) Surges 8.4%: Is This an Indication of Further Gains? Definitive Healthcare (DH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. zacks.com - 3 months ago
8. Profile Summary

Definitive Healthcare Corp. DH

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 291 M
Dividend Yield 0.00%
Description Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Contact 550 Cochituate Road, Framingham, MA, 01701 https://www.definitivehc.com
IPO Date Sept. 15, 2021
Employees 782
Officers Ms. Casey Heller Senior Vice President of Finance Mr. Benjamin Graboske EVice President, Technology, Engineering & Chief Data Officer Mr. Matthew Ruderman Chief Legal Officer & Secretary Ms. Rebecca Marani GM & Senior Vice President of Provider Ms. Kate Hastings Chief Customer Officer Ms. Michelle Liro Senior Vice President of Marketing Mr. Kevin D. Coop Chief Executive Officer & Director Mr. Jason Ronald Krantz Founder & Executive Chairman Mr. Richard Douglas Booth CPA Chief Financial Officer Ms. Kate Marie Shamsuddin Jensen Chief Operating Officer